These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 3553471)

  • 1. Serotonin and the blood-vessel wall.
    Vanhoutte PM
    J Hypertens Suppl; 1986 Dec; 4(5):S112-5. PubMed ID: 3553471
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Serotonin and the blood vessel wall.
    Vanhoutte PM; Lüscher TF
    J Hypertens Suppl; 1986 Apr; 4(1):S29-35. PubMed ID: 2939211
    [TBL] [Abstract][Full Text] [Related]  

  • 3. 5-hydroxytryptamine and vascular disease.
    Vanhoutte PM
    Fed Proc; 1983 Feb; 42(2):233-7. PubMed ID: 6822294
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cardiovascular effects of serotonin.
    Vanhoutte PM
    J Cardiovasc Pharmacol; 1987; 10 Suppl 3():S8-11. PubMed ID: 2446079
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Augmentation of vasoconstrictor responses to serotonin by acute and chronic factors: inhibition by ketanserin.
    Van Nueten JM; Janssens WJ
    J Hypertens Suppl; 1986 Apr; 4(1):S55-9. PubMed ID: 2939213
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Interaction between S2-serotonergic and alpha 1-adrenergic receptor activities at vascular sites.
    Van Nueten JM; Janssens WJ; Xhonneux R; Janssen PA
    J Cardiovasc Pharmacol; 1988; 11 Suppl 1():S10-5. PubMed ID: 2459506
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Serotonin and preactivated platelets in essential hypertension.
    Bühler FR; Amstein R; Fetkovska N
    J Cardiovasc Pharmacol; 1987; 10 Suppl 3():S32-4. PubMed ID: 2446066
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Can peripheral serotonergic blockade explain the hypotensive effect of ketanserin?
    Vanhoutte PM
    J Cardiovasc Pharmacol; 1985; 7 Suppl 7():S105-9. PubMed ID: 2412025
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mechanical and other factors involved in vascular injury related to hypertension.
    Mulvany MJ
    Blood Press Suppl; 1994; 1():11-7. PubMed ID: 8205292
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ketanserin-induced baroreflex enhancement in spontaneously hypertensive rats depends on central 5-HT(2A) receptors.
    Shen FM; Wang J; Ni CR; Yu JG; Wang WZ; Su DF
    Clin Exp Pharmacol Physiol; 2007 Aug; 34(8):702-7. PubMed ID: 17600544
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Free serotonin level in the blood of patients with borderline and essential hypertension].
    Wocial B; Wasowska-Ciszek T; Lapiński M; Januszewicz A; Grzesiuk W; Stepniakowski K; Januszewicz W
    Kardiol Pol; 1990; 33(7):4-7. PubMed ID: 2259064
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Hypertension and vascular diseases: molecular and cellular mechanisms].
    Lüscher TF
    Schweiz Med Wochenschr; 1995 Feb; 125(7):270-82. PubMed ID: 7878405
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Sick vessel syndrome: vascular changes in hypertension and atherosclerosis.
    Heistad DD; Baumbach GL; Faraci FM; Armstrong ML
    J Hum Hypertens; 1995 Jun; 9(6):449-53. PubMed ID: 7473526
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Endothelin: role in hypertension.
    Schiffrin EL
    Biol Res; 1998; 31(3):199-208. PubMed ID: 9830507
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of dipeptidyl peptidase iv inhibition on arterial blood pressure.
    Jackson EK; Dubinion JH; Mi Z
    Clin Exp Pharmacol Physiol; 2008 Jan; 35(1):29-34. PubMed ID: 18047624
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Chronic ouabain treatment exacerbates blood pressure elevation in spontaneously hypertensive rats: the role of vascular mechanisms.
    Xavier FE; Davel AP; Fukuda LE; Rossoni LV
    J Hypertens; 2009 Jun; 27(6):1233-42. PubMed ID: 19337130
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Vascular endothelin in hypertension.
    Schiffrin EL
    Vascul Pharmacol; 2005 Jun; 43(1):19-29. PubMed ID: 15955745
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Platelets, growth factors, and vascular smooth-muscle cells in hypertension and diabetes.
    Mikhail N; Fukuda N; Tremblay J; Hamet P
    J Cardiovasc Pharmacol; 1993; 22 Suppl 6():S64-74. PubMed ID: 7508064
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hypertension, the microcirculation and serotonin.
    Struyker-Boudier HA; le Noble JL; le Noble FA; Messing MW; van Essen H
    Clin Physiol Biochem; 1990; 8 Suppl 3():28-39. PubMed ID: 2132175
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of quinapril, a new angiotensin-converting enzyme inhibitor, on vasoconstrictor activity in the isolated, perfused mesenteric vasculature of hypertensive rats.
    Major TC; Overhiser RW; Taylor DG; Panek RL
    J Pharmacol Exp Ther; 1993 Apr; 265(1):187-93. PubMed ID: 8474005
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.